Tyler Jensen, SVP, Engineering and Technology Development at GenMark Diagnostics, Inc. (GNMK), sold 500 shares at $23.88 ($12K) on 2021-03-18, disclosed to the SEC on 2021-03-22.
Scheduled sale ($12k) by SVP, Engineering and Technology Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| GNMK | SELL | 2021-02-16 | $220K | — | Filing → |
| GNMK | SELL | 2021-02-08 | $7K | — | Filing → |
| GNMK | SELL | 2021-01-29 | $5K | — | Filing → |